Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oral biofilm development is a multistep process in which communities of microorganisms adhere to and colonize surfaces in the oral cavity (such as teeth, dental materials, or soft tissues), forming a structured, protective extracellular matrix known as biofilm. This process involves initial microbial adhesion, proliferation, maturation, and eventual dispersion, leading to complex microbial ecosystems resilient to antimicrobial drugs and immune clearance. Oral biofilms are primarily responsible for dental plaque and are implicated in diseases such as dental caries, periodontitis, peri-implantitis, and can serve as reservoirs for systemic infections. Controlling oral biofilm involves diverse antimicrobial, mechanical, and targeted strategies due to their high resistance to conventional therapies
Drugs may work by disrupting microbial adhesion, inhibiting EPS synthesis, or killing embedded bacteria; these do not target a single molecule but act via multiple anti-biofilm strategies
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oral biofilm development.